MicroRNA-148a facilitates inflammatory dendritic cell differentiation and autoimmunity by targeting MAFB
MicroRNA-148a facilitates inflammatory dendritic cell differentiation and autoimmunity by targeting MAFB
复制标题
MicroRNA-148a 通过靶向 MAFB 促进炎症树突状细胞分化和自身免疫
DOI:
10.1172/jci.insight.133721
复制
发表时间:
2020
期刊:
影响因子:
8
通讯作者:
Shen Nan
中科院分区:
文献类型:
--
作者:
Meng Yao;Li Jun;Ye Zhizhong;Yin Zhihua;Sun Qing;Liao Zhuojun;Li Guanhua;Deng Jun;Liu Lu;Yu Yuqing;Wu Li;Zhou Haibo;Shen Nan
Monocyte-derived DCs (moDCs) have been implicated in the pathogenesis of autoimmunity, but the molecular pathways determining the differentiation potential of these cells remain unclear. Here, we report that microRNA-148a (miR-148a) serves as a critical regulator for moDC differentiation. First, miR-148a deficiency impaired the moDC development in vitro and in vivo. A mechanism study showed that MAFB, a transcription factor that hampers moDC differentiation, was a direct target of miR-148a. In addition, a promoter study identified that miR-148a could be transcriptionally induced by PU.1, which is crucial for moDC generation. miR-148a ablation eliminated the inhibition of PU.1 on MAFB. Furthermore, we found that miR-148a increased in monocytes from patients with psoriasis, and miR-148a deficiency or intradermal injection of antagomir-148a immensely alleviated the development of psoriasis-like symptoms in a psoriasis-like mouse model. Therefore, these results identify a pivotal role for the PU.1-miR-148a-MAFB circuit in moDC differentiation and suggest a potential therapeutic avenue for autoimmunity.